On July 14, 2025, JP Morgan analyst Jessica Fye reaffirmed the Neutral rating for Incyte (INCY, Financial). The company's stock continues to hold a balanced potential for both risks and rewards as per the analyst's assessment.
In an effort to reflect the current market conditions and outlook, JP Morgan has adjusted its price target for INCY from USD 68.00 to USD 67.00, marking a 1.47% decrease. This adjustment indicates a cautious stance amidst evolving market dynamics.
The decision to maintain the Neutral rating suggests that INCY is expected to perform in line with the broader market. Investors are advised to consider this updated price target and rating when evaluating their positions in Incyte.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 20 analysts, the average target price for Incyte Corp (INCY, Financial) is $76.37 with a high estimate of $107.00 and a low estimate of $52.00. The average target implies an upside of 10.68% from the current price of $69.00. More detailed estimate data can be found on the Incyte Corp (INCY) Forecast page.
Based on the consensus recommendation from 27 brokerage firms, Incyte Corp's (INCY, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Incyte Corp (INCY, Financial) in one year is $99.26, suggesting a upside of 43.87% from the current price of $68.995. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Incyte Corp (INCY) Summary page.
